PRINCETON, N.J., March 22 /PRNewswire-FirstCall/ -- Cancer survivor and six-time Tour de France champion Lance Armstrong and Bristol-Myers Squibb announced today that applications are being accepted for the 2005 Bristol- Myers Squibb Tour of Hope(TM) National Team. The cancer community is seeking survivors, physicians, nurses, caregivers, researchers, and advocates to be part of this unique experience this fall. Twenty extraordinary people who possess the cycling ability and physical endurance to ride over 100 miles a day for nine days, combined with a passionate commitment to support clinical trials and cancer research, will be selected by members of the cancer community. Applications are due by midnight EDT, April 20, 2005. Selected team members are expected to be notified in late May.
Cancer research and clinical trials are critical in advancing prevention, diagnosis, and treatment of cancer. However, the search for a cure is being slowed due to the less than five percent of eligible adults who participate in cancer research studies. The goal of the Tour of Hope is to dispel the myths about clinical trials, and urge Americans to become more educated about the vital importance of cancer research.
The Tour of Hope will begin in San Diego on Thursday, September 29 and conclude in Washington, DC on Saturday, October 8 with a grand finale celebration and public fundraising ride. To apply for the 20-person National Team, obtain information on other ways to support the Tour of Hope, or to learn about cancer research and clinical trials, visit http://www.tourofhope.org/.
The following cancer community partners support the Bristol-Myers Squibb Tour of Hope(TM): American Society of Clinical Oncology Foundation, C-Change, CancerCare, Cancer Research and Prevention Foundation, the Coalition of National Cancer Cooperative Groups, Lance Armstrong Foundation, the National Coalition of Cancer Survivorship, and the Oncology Nursing Society.
Bristol-Myers Squibb is a global pharmaceutical and related health care products company whose mission is to extend and enhance human life.
CONTACT: Kathy Baum, Bristol-Myers Squibb, +1-609-252-4227; or PamLippincott, Spectrum Science Communications, +1-202-955-6222, forBristol-Myers Squibb